Welcome to Decoding Bio, a writing collective focused on the latest scientific advancements, news, and people building at the intersection of tech x bio.
I think there might be a typo in today's article. Sanofi acquired one of the assets of Inhibrx but in your article it mentions J&J acquired Inhibrx followed by correct mention of Sanofi buying 8% stake in spun out company.
Hi Decoding Bio Team,
Truly enjoy your BioBytes each week!
I think there might be a typo in today's article. Sanofi acquired one of the assets of Inhibrx but in your article it mentions J&J acquired Inhibrx followed by correct mention of Sanofi buying 8% stake in spun out company.
Let me know if I made wrong assumptions
Thanks
Thank you so much for pointing it out, a clearly silly mistake!